Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ludong Bai"'
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Schizophrenia is ranked among the top 25 leading causes of disability worldwide in 2013 which resulting in social and economic burden. By observing patients with schizophrenia one year before and after switching from oral antipsychotics (OAP
Externí odkaz:
https://doaj.org/article/a418a60240554af48161f466ca2899dd
Autor:
Gang Wang, Le Xiao, Hongye Ren, Kenneth Simonsen, Jingdong Ma, Xiangdong Xu, Ping Guo, Zhiren Wang, Ludong Bai, Elin Heldbo Reines, Lene Hammer-Helmich
Publikováno v:
Neuropsychiatric Disease and Treatment. 18:1939-1950
Gang Wang,1,* Le Xiao,1,* Hongye Ren,2 Kenneth Simonsen,2 Jingdong Ma,3 Xiangdong Xu,4 Ping Guo,5 Zhiren Wang,6 Ludong Bai,7 Elin Heldbo Reines,2 Lene Hammer-Helmich2 1The National Clinical Research Center for Mental Disorders & Beijing Key L
Autor:
Zhongbao Wang, Yunshao Zheng, Yunli Fan, Yunming Fan, Xianbiao Su, Bingrui Wang, Jing Li, Diancai Chen, Fengxia Sun, Shen Li, Jiashu Ma, Xianwei Li, Ludong Bai, Ranran Li
Publikováno v:
Neuropsychiatric Disease and Treatment.
Zhongbao Wang,1 Yunshao Zheng,2 Yunli Fan,2 Yunming Fan,2 Xianbiao Su,2 Bingrui Wang,2 Jing Li,2 Diancai Chen,2 Fengxia Sun,2 Shen Li,2 Jiashu Ma,1 Xianwei Li,2 Ludong Bai,2 Ranran Li2 1Department of Psychiatry, Jining Medical University, Jining, Peo
Background: Schizophrenia is ranked among the top 25 leading causes of disability worldwide in 2013 which resulting in social and economic burden. By observing patients with schizophrenia one year before and after switching from oral antipsychotics (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7f8c563b446aed16774fa8ed52ca48b
https://doi.org/10.21203/rs.3.rs-620450/v1
https://doi.org/10.21203/rs.3.rs-620450/v1
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-7 (2022)
Schizophrenia is ranked among the top 25 leading causes of disability worldwide in 2013 which resulting in social and economic burden. By observing patients with schizophrenia one year before and after switching from oral antipsychotics (OAPs) to onc
Autor:
Xueyi Wang, Jian Xie, Ludong Bai, Xiumin You, Jinan Wang, Cuili Hu, Gang Wang, Jianmin Zhuo, QiZhong Yi, Zhijian Yao, Xiufeng Xu, Jun Ma
Publikováno v:
Neuropsychiatric Disease and Treatment
Gang Wang,1 Xiumin You,2 Xueyi Wang,3 Xiufeng Xu,4 Ludong Bai,5 Jian Xie,6 Zhijian Yao,7 QiZhong Yi,8 Jun Ma,9 Jinan Wang,10 Jianmin Zhuo,11 Cuili Hu11 1Psychiatry Department, Beijing Anding Hospital, Capital Medical University, National Clinical Res